GlassScriptPhysician profile
Brian W Blanchette
NPI 1821071861
$716.04
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $76.33 · 2021: $229 · 2022: $70.23 · 2023: $105 · 2024: $16.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $121.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $74.43 | 2019 | |
| Abbvie INC. | $66.22 | 2023-2024 | Vraylar |
| Takeda Pharmaceuticals U.S.A., INC. | $63.46 | 2021 | |
| Novo Nordisk INC | $59.78 | 2019-2021 | |
| Amgen INC. | $58.21 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $54.80 | 2019-2022 | |
| Glaxosmithkline, LLC. | $46.92 | 2021-2022 | |
| Pfizer INC. | $41.27 | 2019-2022 | |
| Astellas Pharma US INC | $34.16 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $31.24 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $25.55 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $24.98 | 2023 | Farxiga |
| Eisai INC. | $24.83 | 2021 | |
| Nestle Healthcare Nutrition INC. | $22.20 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.13 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15.63 | 2023 | |
| Amarin Pharma, INC. | $15.26 | 2019 | |
| Abbott Laboratories | $14.58 | 2023 | Freestyle Libre 3 |
| Sanofi Pasteur INC. | $14.10 | 2020 | |
| Dynavax Technologies Corporation | $9.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Blanchette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.